rxstat › Classes › Drugs Used In Benign Prostatic Hypertrophy

Drugs Used In Benign Prostatic Hypertrophy: shortage status in Canada

5 of the 8 drugs used in benign prostatic hypertrophy rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Alfuzosin (Xatral) Partial shortage 1 of 6 reported products affected Dutasteride Partial shortage 1 of 12 reported products affected · est. return Aug 1, 2026 Finasteride (Proscar) Partial shortage 2 of 18 reported products affected · est. return Dec 31, 2026 Tamsulosin (Flomax) Partial shortage 4 of 10 reported products affected · est. return Nov 13, 2026 Terazosin Partial shortage 1 of 18 reported products affected · est. return Aug 14, 2026 Silodosin (Rapaflo) No current shortage Tamsulosin Dutasteride (Jalyn) No current shortage Terazosin (Hytrin) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.